Surgical oncology during the post-COVID-19 era: What is next?
Georgios D LianosMaximos FrountzasDimitrios SchizasEvangelos G BaltagiannisGeorge A AlexiouChristina BaliGeorgios K GlantzounisMichail MitsisKonstantinos VlachosPublished in: Journal of surgical oncology (2022)
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered.